Insights into the structure–activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A role played by the lactone moiety

Haibo Qiu, Shan Qian, Sarah A. Head, Jun Liu, Zhendong Jin

Research output: Contribution to journalArticle

Abstract

Compound ZJ-101, a structurally simplified analog of the marine natural product superstolide A, was previously developed in our laboratory. In the subsequent structure–activity relationship study, a new analog ZJ-109 was designed and synthesized to probe the importance of the lactone moiety of the molecule by replacing the lactone in ZJ-101 with a lactam. The biological evaluation showed that ZJ-109 is about 8–12 times less active against cancer cells in vitro than ZJ-101, suggesting that the lactone moiety of the molecule is important for its anticancer activity.

Original languageEnglish (US)
Pages (from-to)4702-4704
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume26
Issue number19
DOIs
StatePublished - Oct 1 2016

Fingerprint

Lactones
Biological Products
Derivatives
Lactams
Molecules
Cells
superstolide A
Neoplasms

Keywords

  • Anticancer agent
  • Asymmetric synthesis
  • Drug design
  • Structure–activity relationship
  • Superstolide A analog

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Insights into the structure–activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A : A role played by the lactone moiety. / Qiu, Haibo; Qian, Shan; Head, Sarah A.; Liu, Jun; Jin, Zhendong.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 26, No. 19, 01.10.2016, p. 4702-4704.

Research output: Contribution to journalArticle

@article{814c46c1f767440abc2a66799815777d,
title = "Insights into the structure–activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A role played by the lactone moiety",
abstract = "Compound ZJ-101, a structurally simplified analog of the marine natural product superstolide A, was previously developed in our laboratory. In the subsequent structure–activity relationship study, a new analog ZJ-109 was designed and synthesized to probe the importance of the lactone moiety of the molecule by replacing the lactone in ZJ-101 with a lactam. The biological evaluation showed that ZJ-109 is about 8–12 times less active against cancer cells in vitro than ZJ-101, suggesting that the lactone moiety of the molecule is important for its anticancer activity.",
keywords = "Anticancer agent, Asymmetric synthesis, Drug design, Structure–activity relationship, Superstolide A analog",
author = "Haibo Qiu and Shan Qian and Head, {Sarah A.} and Jun Liu and Zhendong Jin",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.bmcl.2016.08.046",
language = "English (US)",
volume = "26",
pages = "4702--4704",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "19",

}

TY - JOUR

T1 - Insights into the structure–activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A

T2 - A role played by the lactone moiety

AU - Qiu, Haibo

AU - Qian, Shan

AU - Head, Sarah A.

AU - Liu, Jun

AU - Jin, Zhendong

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Compound ZJ-101, a structurally simplified analog of the marine natural product superstolide A, was previously developed in our laboratory. In the subsequent structure–activity relationship study, a new analog ZJ-109 was designed and synthesized to probe the importance of the lactone moiety of the molecule by replacing the lactone in ZJ-101 with a lactam. The biological evaluation showed that ZJ-109 is about 8–12 times less active against cancer cells in vitro than ZJ-101, suggesting that the lactone moiety of the molecule is important for its anticancer activity.

AB - Compound ZJ-101, a structurally simplified analog of the marine natural product superstolide A, was previously developed in our laboratory. In the subsequent structure–activity relationship study, a new analog ZJ-109 was designed and synthesized to probe the importance of the lactone moiety of the molecule by replacing the lactone in ZJ-101 with a lactam. The biological evaluation showed that ZJ-109 is about 8–12 times less active against cancer cells in vitro than ZJ-101, suggesting that the lactone moiety of the molecule is important for its anticancer activity.

KW - Anticancer agent

KW - Asymmetric synthesis

KW - Drug design

KW - Structure–activity relationship

KW - Superstolide A analog

UR - http://www.scopus.com/inward/record.url?scp=84985894818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985894818&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2016.08.046

DO - 10.1016/j.bmcl.2016.08.046

M3 - Article

C2 - 27595422

AN - SCOPUS:84985894818

VL - 26

SP - 4702

EP - 4704

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 19

ER -